Hemmo Pharmaceuticals

Mumbai, India Founded: 1979 • Age: 47 yrs Acquired By Piramal Pharma Solutions
Synthetic peptides are manufactured for research, clinical, and commercial applications.
Request Access

About Hemmo Pharmaceuticals

Hemmo Pharmaceuticals is a company based in Mumbai (India) founded in 1979 was acquired by Piramal Pharma Solutions in March 2021.. Hemmo Pharmaceuticals operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $2.48 M (USD)
    -71
    as on Mar 31, 2024
  • Net Profit
    $1.76 M (USD)
    -71
    as on Mar 31, 2024
  • EBITDA
    $2.26 M (USD)
    -72
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Hemmo Pharmaceuticals

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Hemmo Pharmaceuticals

Hemmo Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Pharma Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Serves as a contract manufacturer of pharmaceutical products for industry partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Hemmo Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Hemmo Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hemmo Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Hemmo Pharmaceuticals

Hemmo Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
domain founded_year HQ Location
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
domain founded_year HQ Location
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
domain founded_year HQ Location
Integrated drug discovery and preclinical development services are provided.
domain founded_year HQ Location
Fluorinated compounds are synthesized and manufactured customly for various industries.
domain founded_year HQ Location
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hemmo Pharmaceuticals

Frequently Asked Questions about Hemmo Pharmaceuticals

When was Hemmo Pharmaceuticals founded?

Hemmo Pharmaceuticals was founded in 1979.

Where is Hemmo Pharmaceuticals located?

Hemmo Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

What is the annual revenue of Hemmo Pharmaceuticals?

Annual revenue of Hemmo Pharmaceuticals is $2.48M as on Mar 31, 2024.

What does Hemmo Pharmaceuticals do?

Hemmo Pharmaceuticals was founded in 1979 and is based in Mumbai, India. Operations focus on the pharmaceutical sector, where synthetic peptides are produced for research, clinical development, and commercial use in human and veterinary industries. Products are exported globally, with bulk Oxytocin supplied to international markets. The portfolio encompasses generic active pharmaceutical ingredients, custom research peptides, clinical peptides, and peptide fragments.

Who are the top competitors of Hemmo Pharmaceuticals?

Hemmo Pharmaceuticals's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.

Who are Hemmo Pharmaceuticals's investors?

Hemmo Pharmaceuticals has 1 investor. Key investors include Piramal Pharma Solutions.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available